IOT Member Communications

Thank you to everyone that attended our collaborative ‘World Trichology Conference’ in 2023, and for your wonderful feedback about the success of this event. Our next ‘face-to-face’ conference will be scheduled for 2025. This year we will be inviting you to attend our exciting on-line CPD webinars. We invite you to take a few moments […]

*This event is not an IOT Educational Programme, but a series of interviews with practitioners in all areas of hair and scalp health. The interviews are by Renae Miller, Founder of ‘Complete Image Clinic’, Cleveland, Ohio.* Please find some information below on the “From the Hair Down” event, featuring the IOT’s Chairman Neil Harvey MIT.

Patients, service users and the public can now choose a Trichologist belonging to a register vetted and approved by the Professional Standards Authority for Health and Social Care (the Authority), an independent statutory body, accountable to Parliament. The Institute of Trichologists’ (IOT) register has been accredited under the Accredited Registers programme. Trichologists on the IOT’s

Important – Please Read Some time ago – the Board took the decision to look closely at registration with the Professional Standards Authority (PSA). This decision was taken in order to provide improved confidence in Trichology as a sector of the health care profession, to be recognised as a more professionally accepted and closely ‘governed’

Important – Please Read At present, there is very little regulation to help protect patients regarding qualifications required in determining who can administer invasive treatments/injectables. There are consultations in process which mean this SHOULD come into place within the next few years. At present, microdermabrasion is considered a beauty therapist led procedure, but the ‘general

Please see the information below that has been sent to us to share with our members, regarding a double-blind controlled trial of a new topical treatment for mild-moderate alopecia areata that has recently started in the UK. The trial is sponsored by a UK pharma company (Manentia). Members of The Institute of Trichologists have been